TickerGuard
Buy Day today: Good (62) Broad market participation · no major macro event
ARQT

Arcutis Biotherapeutics Inc

Healthcare · Biotechnology

26.50$ +1.2% vs. previous close Closing price · As of: Sep 17, 2026

Statements

Income Statement

Arcutis Biotherapeutics Inc (ARQT) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Revenue" came in at 376 million USD. Tick rows to compare them in a chart.

All figures in millions of USD.

Tick rows to compare them in a chart (up to 4)

Income Statement ARQT
Line item 2017 2018 2019 2020 2021 2022 2023 2024 2025
0.0 0.0 0.0 0.0 0.0 3.7 60 197 376
0.2 0.5 0.8 0.8 5.0 19 37
-0.2 -0.5 -0.8 2.9 55 177 339
3.4 18 37 115 146 182 111 76 77
0.7 1.8 6.6 21 61 122 173 222 275
4.1 20 43 136 207 305 296 306 352
-4.1 -20 -43 -137 -207 -302 -241 -128 -12
0.0 0.0 0.0 0.0 0.5 16 30 27 12
-5.0 -19 -42 -136 -206 -311 -259 -139 -15
-4.1 -0.5 0.0 -0.1 -0.5 9.8 3.1 0.6 1.2
-5.0 -19 -42 -136 -206 -311 -262 -140 -16
-4.1 -19 -42 -135 -206 -295 -227 -110 2.5

Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?